N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (1) , 39-46
- https://doi.org/10.1016/0192-0561(88)90148-8
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infectionEuropean Journal of Clinical Investigation, 1986
- A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosisEuropean Journal of Pediatrics, 1985
- Chlorpromazine Inhibits Neutrophil Chemotaxis Beyond the Chemotactic Receptor-Ligand InteractionThe Journal of Infectious Diseases, 1984
- Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function.Journal of Clinical Investigation, 1984
- Enhancement of chemiluminescence of the neutrophils by low concentrations of trifluoperazineBiochemical and Biophysical Research Communications, 1984
- Adult Respiratory-Distress SyndromeNew England Journal of Medicine, 1982
- Acetaminophen OverdoseArchives of internal medicine (1960), 1981
- The use of N-acetylcysteine in the treatment of cystic fibrosisThe Journal of Pediatrics, 1964